Roche Diagnostics Africa Launches Integration Accelerated on World TB Day 2026
On World TB Day 2026, Roche Diagnostics Africa unveiled a groundbreaking initiative called Integration Accelerated. This program aims to enhance access to diagnostics and optimize the use of existing healthcare infrastructure across various African nations.
The Ongoing Challenge of Tuberculosis
Despite notable advancements in combating tuberculosis (TB), it remains the world’s deadliest infectious disease. In 2024, the global statistics for TB are alarming, with an estimated 10.7 million cases and 1.23 million deaths reported1. While Africa has made remarkable strides, reducing new cases by 28% and deaths by 46% since 20152, the continent still endures a heavy burden, accounting for about a quarter of new infections and over 30% of deaths3.
Moreover, a significant number of cases remain undiagnosed or unreported, exacerbated by the intricate relationship between TB and HIV, complicating care delivery in numerous regions3.
Emphasizing Efficiency and Integration
In light of constrained resources, it is crucial to leverage existing technologies and infrastructure to enhance access to care. Integration Accelerated is a strategic initiative that capitalizes on established HIV diagnostic platforms to facilitate additional testing for TB, Human Papillomavirus (HPV), and Hepatitis. This comprehensive approach allows countries to maximize their current systems, adopting a “whole patient” view while enhancing laboratory efficiency without additional capital outlays.
Aligning with National Health Priorities
The initiative aligns with the growing focus on scalable, cost-effective health solutions throughout Africa, reinforcing long-term resilience and improved patient outcomes. Integration Accelerated emphasizes the optimization of existing diagnostic capacities through an all-inclusive model that promotes cost savings across various infectious diseases while providing tailored technical support for implementation in diverse contexts.
Transformative Perspectives from Industry Leaders
The Executive Vice President for Roche Diagnostics, Africa, Dr. Allan Pamba, stated: “In 2025, the world stopped funding the old way of doing health. In 2026, Roche launches a new way. We aim to make Integration Accelerated the catalyst for countries across Africa to increase their impact within the realities of budget constraints.”
Dr. Pamba further emphasized: “Integration Accelerated helps break the vertical, donor-driven silos to build resilient, integrated health systems of the future. By integrating TB, HPV, and Hepatitis testing onto the extensive footprint of HIV instruments already in place, it transforms spare capacity into timely life-saving diagnostic results and enables holistic patient care.”
Boosting Healthcare Efficiency with Integration Accelerated
Roche stands as a prominent industry partner, providing the necessary solutions and technical assistance to execute this vital change in various local contexts across Africa. The Integration Accelerated model aims to optimize current medium and high-volume diagnostic instruments, helping countries avoid unnecessary additional investments.
This access model, encompassing HIV, TB, HPV, and Hepatitis B and C, will yield significant savings for Ministries of Health. The initiative also offers a customizable menu of technical assistance to support integration efforts tailored to individual country needs.
Conclusion: A Pathway to Improved Health Outcomes
As nations strive to strengthen their TB responses, Integration Accelerated presents a clear and actionable pathway to broaden access, enhance efficiency, and foster better-coordinated results for patients.
